News of his passing emerged on November 5, 2026, through a heartfelt tribute published by his longtime friend and colleague, Gil Bashe, in Medika Life. According to Bashe, the two had spoken about artificial intelligence and human cognition just one day before Nosta’s death.
Nosta built an influential career exploring the relationship between technology, neuroscience and healthcare. His professional journey included work in cardiovascular science, with connections to Harvard Medical School and Brigham and Women’s Hospital. He later moved into marketing and innovation, including a senior executive position at Ogilvy.
As founder of NostaLab, he became a respected voice in international discussions about digital health and artificial intelligence. Rather than simply celebrating technological advancement, he encouraged healthcare professionals to consider how innovation could support human judgment and improve patient care.
He also contributed articles and interviews to ICT&health and was in discussions about delivering a keynote address at its World Conference.
Details about his age, early family life, spouse and children have not been publicly confirmed.
John Nosta’s passing leaves a significant absence in healthcare innovation. His questions, ideas and commitment to human-centred progress will continue to inspire conversations about medicine’s future.